Stallergenes Greer
London
About Stallergenes Greer
Stallergenes Greer is a global biopharmaceutical company specializing in the diagnosis and treatment of respiratory allergies through the development and commercialization of Allergy Immunotherapy products and services. Our purpose is to enable people with allergies to live normal lives. With more than 1,400 employees worldwide, a presence in 75 countries, and manufacturing facilities in both Europe and the United States, Stallergenes Greer plc is the parent company of GREER Laboratories, Inc. (whose registered office is in the U.S.) and Stallergenes S.A.S. (whose registered office is in France).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 1,001 – 5,000
- Estimated revenue: $10M+
- Total funding: $53.3M
- Funding stage: M&A
- Last round: Post-IPO Debt (Dec 2016)
- Ticker: epa:STAGR
- Website: stallergenesgreer.com
- Phone: +44-20-72394500
Industries & Categories
Biopharma, Health Care, Hospital, Medical Device, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/stallergenes-greer-79711 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.